Clinical outcome of percutaneous treatment of in-stent restenosis with drug-eluting stents: Results from the first phase of the prospective multicentre German DES.DE registry

EuroIntervention

Volumn 7, Issue 2, 2011, Pages 201-208

  Abdel Wahab, Mohamed ^a   Nienaber, Christoph A ^b   Mostafa, Ahmad E ^a   Sabin, Georg ^c   Tebbe, Ulrich ^d   Hochadel, Matthias ^e   Senges, Jochen ^e   Akin, Ibrahim ^b   Kuck, Karl Heinz ^f   Hamm, Christian ^g   Richardt, Gert ^a  

^a UNIVERSITY HOSPITAL SCHLESWIG HOLSTEIN   (Germany)

^b ROSTOCK UNIVERSITY MEDICAL CENTER   (Germany)

^c ELISABETH KRANKENHAUS ESSEN   (Germany)

^d KLINIKUM LIPPE DETMOLD   (Germany)

^e UNIVERSITY OF HEIDELBERG   (Germany)

^f Asklepios Hospital North   (Germany)

^g KERCKHOFF HEART CENTER   (Germany)

Author keywords

Drug eluting stents; In stent restenosis; Registry

Indexed keywords

CLOPIDOGREL; CYPHER; GLYCOPROTEIN IIB; GLYCOPROTEIN IIIA; PACLITAXEL; RAPAMYCIN; UNCLASSIFIED DRUG;

AGED; ARTICLE; CONTROLLED STUDY; DEATH; DRUG EFFICACY; DRUG ELUTING STENT; FEMALE; HEART INFARCTION; HUMAN; IN-STENT RESTENOSIS; LOADING DRUG DOSE; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; OUTCOME ASSESSMENT; PERCUTANEOUS CORONARY INTERVENTION; RANDOMIZED CONTROLLED TRIAL; STENT THROMBOSIS; STROKE; TREATMENT RESPONSE; ANGIOCARDIOGRAPHY; CLINICAL TRIAL; GERMANY; METHODOLOGY; MIDDLE AGED; PROSPECTIVE STUDY; REGISTER; RESTENOSIS; STATISTICS; STENT; TRANSLUMINAL CORONARY ANGIOPLASTY; TREATMENT OUTCOME;

AGED; ANGIOPLASTY, BALLOON, CORONARY; CORONARY ANGIOGRAPHY; CORONARY RESTENOSIS; DRUG-ELUTING STENTS; FEMALE; GERMANY; HUMANS; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; REGISTRIES; STENTS; TREATMENT OUTCOME;

EID: 80054055934     PISSN: 1774024X     EISSN: 19696213     Source Type: Journal    
DOI: 10.4244/EIJV7I2A34     Document Type: Article

References (20)

1. Serruys PW, de Jaegere P, Kiemeneij F, Macaya C, Rutsch W, Heyndrickx G, Emanuelsson H, Marco J, Legrand V, Materne P, Belardi J, Sigwart U, Colombo A, Goy JJ, van den Heuvel P, Delcan J, Morel MA; for the Benestent Study Group. A comparison of balloon-expandable stent implantation with balloon angioplasty in patients with coronary artery disease. Benestent Study Group. N Engl J Med 1994;331:489-495. (Pubitemid 24256751)
2. Kastrati A, Schömig A, Dietz R, Neumann FJ, Richardt G. Time course of restenosis during the first year after emergency coronary stenting. Circulation 1993;87:1498-1505. (Pubitemid 23133093)
3. Lee MS, Pessegueiro A, Zimmer R, Jurewitz D, Tobis J. Clinical presentation of patients with in-stent restenosis in the drug-eluting era. J Invasive Cardiol 2008;20:401-403.
4. Walters DL, Harding SA, Walsh CR, Wong P, Pomerantsev E, Jang IK. Acute coronary syndrome is a common clinical presentation of in-stent restenosis. Am J Cardiol 2002;89:491-494. (Pubitemid 34178555)
5. Chen MS, John JM, Chew DP, Lee DS, Ellis SG, Bhatt DL. Bare metal stent restenosis is not a benign clinical entity. Am Heart J 2006;151:1260-1264. (Pubitemid 43866610)
6. Kastrati A, Mehilli J, von Beckerath N, Dibra A, Hausleiter J, Pache J, Schühlen H, Schmitt C, Dirschinger J, Schömig A; ISARDESIRE Study Investigators. Sirolimus-eluting stent or paclitaxeleluting stent vs balloon angioplasty for prevention of recurrences in patients with coronary in-stent restenosis: a randomized controlled trial. JAMA 2005;293:165-71. (Pubitemid 40095867)
7. Alfonso F, Pérez-Vizcayno MJ, Hernández R, Bethencourt A, Martí V, López-Mínguez JR, Angel J, Iñiguez A, Morís C, Cequier A, Sabaté M, Escaned J, Jiménez-Quevedo P, Bañuelos C, Suárez A, Macaya C; RIBS-II Investigators. Long-term clinical benefit of sirolimus-eluting stents in patients with in-stent restenosis: results of the RIBS-II (Restenosis Intra-stent: Balloon angioplasty vs. elective sirolimus-eluting Stenting) study. J Am Coll Cardiol 2008;52:1621-7.
8. Holmes DR Jr, Teirstein PS, Satler L, Sketch MH Jr, Popma JJ, Mauri L, Wang HP, Schleckser PA, Cohen SA; SISR Investigators. 3-year follow-up of the SISR (Sirolimus-Eluting Stents Versus Vascular Brachytherapy for In-Stent Restenosis) trial. JACC Cardiovasc Interv 2008;1:439-48.
9. Stone GW, Ellis SG, O'Shaughnessy CD, Martin SL, Satler L, McGarry T, Turco MA, Kereiakes DJ, Kelley L, Popma JJ, Russell ME; TAXUS V ISR Investigators. Paclitaxel-eluting stents vs vascular brachytherapy for in-stent restenosis within bare-metal stents: the TAXUS V ISR randomized trial. JAMA 2006;295: 1253-63.
10. Dibra A, Kastrati A, Alfonso F, Seyfarth M, Pérez-Vizcayno MJ, Mehilli J, Schömig A. Effectiveness of drug-eluting stents in patients with bare-metal in-stent restenosis: meta-analysis of randomized trials. J Am Coll Cardiol 2007;49:616-23. (Pubitemid 46177448)
11. Möllmann H, Elsässer A, Nef H, Schneider S, Nienaber CA, Richardt G, Weber M, Kelm M, Levenson B, Bonzel T, Tebbe U, Sabin G, Pfannebecker T, Senges J, Hamm CW. Treatment of instent restenosis with sirolimus-eluting-stents: results from the prospective German Cypher stent registry. Clin Res Cardiol 2008;97:432-40.
12. Nienaber CA, Akin I, Schneider S, Senges J, Fetsch T, Tebbe U, Willich SN, Stumpf J, Sabin GV, Silber S, Richardt G, Kuck KH; DES.DE Study Group. Clinical outcomes after sirolimus-eluting, paclitaxel-eluting and bare metal stents (from the first phase of the prospective multicenter German DES.DE Registry). Am J Cardiol 2009;104:1362-9.
13. Cutlip DE, Windecker S, Mehran R, Boam A, Cohen DJ, van Es GA, Steg PG, Morel MA, Mauri L, Vranckx P, McFadden E, Lansky A, Hamon M, Krucoff MW, Serruys PW; Academic Research Consortium. Clinical end points in coronary stent trials: a case for standard definitions. Circulation 2007;115:2344-2351. (Pubitemid 46685903)
14. Le Feuvre C, Healy-Brucker A, Helft G, Monségu J, Varenne O, Spaulding C, Collet JP, Beygui F, Barthélémy O, Choussat R, Montalescot G, Metzger JP. Long-term follow-up of patients with sirolimus-eluting stents for treatment of bare-metal in-stent restenosis. Int J Cardiol 2010;140:219-25.
15. Liistro F, Fineschi M, Grotti S, Angioli P, Carrera A, Ducci K, Gori T, Falsini G, Pierli C, Bolognese L. Long-term effectiveness and safety of sirolimus stent implantation for coronary in-stent restenosis: results of the TRUE (Tuscany Registry of Sirolimus for Unselected In-Stent Restenosis) registry at 4 years. J Am Coll Cardiol 2010:55;613-616.
16. Dibra A, Kastrati A, Mehilli J, Pache J, Schühlen H, von Beckerath N, Ulm K, Wessely R, Dirschinger J, Schömig A; ISARDIABETES Study Investigators. Paclitaxel-eluting or sirolimuseluting stents to prevent restenosis in diabetic patients. N Engl J Med 2005; 353:663-70. (Pubitemid 41175674)
17. Mehilli J, Dibra A, Kastrati A, Pache J, Dirschinger J, Schömig A. Randomized trial of paclitaxel-and sirolimus-eluting stents in small coronary vessels. Eur Heart J 2006;27:260-6. (Pubitemid 43100018)
18. Scheller B, Hehrlein C, Bocksch W, Rutsch W, Haghi D, Dietz U, Bohm M, Speck U. Treatment of coronary in-stent restenosis with a paclitaxel-coated balloon catheter. N Engl J Med 2006;355:2113-24. (Pubitemid 44749319)
19. Unverdorben M, Vallbracht C, Cremers B, Heuer H, Hengstenberg C, Maikowski C, Werner GS, Antoni D, Kleber FX, Bocksch W, Leschke M, Ackermann H, Boxberger M, Speck U, Degenhardt R, Scheller B. Paclitaxel-coated balloon catheter versus paclitaxel-coated stent for the treatment of coronary in-stent restenosis. Circulation 2009;119:2986-94.
20. Hamm CW. Paclitaxel-eluting PTCA-balloon in combination with the Cloroflex Blue stent vs. the sirolimus-coated Cypher stent in the treatment of advanced coronary artery disease. Paper presented at: American Heart Association Scientific Sessions 2009; November 14, 2009; Orlando, FL.